ELG Law

Revlon: toxic hair relaxers

The results of a recent National Institutes of Health study prompted several product liability lawsuits against Revlon and other cosmetics companies. The plaintiffs in these lawsuits claim that the chemical hair relaxers manufactured and marketed by the beauty company can cause the development of hormone-sensitive cancer.

Do you suspect that regular and prolonged use of chemical hair relaxers caused uterine or ovarian cancer? We strongly advise you to contact our law firm for a free consultation. Our attorneys can help you file a toxic hair relaxer claim against the manufacturer with minimal involvement at your end. You only need to provide evidence of chemical hair relaxer use and your medical records to confirm your diagnosis.

Long-term, frequent use of Revlon hair relaxers may be linked to increased risk of:

Plaintiffs in toxic hair relaxer lawsuits claim that prolonged use of chemical hair relaxers marketed by the cosmetics company can cause severe health conditions in women. The complaints filed toxic hair relaxer claims against the company, accusing Revlon of promoting its hair straightening products toward women of color while failing to warn about the danger that some of the chemical compounds pose for human health.

If you used Creme of Nature hair relaxers, you should know that you need to meet some eligibility requirements to file a toxic hair relaxer claim against Revlon:

  • you must have used Creme of Nature chemical hair relaxers for at least 2 - 5 years
  • you must have used Creme of Nature chemical hair relaxer products at least four times a year
  • you must have medical records that confirm your ovarian or uterine cancer diagnosis

Key facts

Active MDL

MDL 3060, N.D. Ill.

Key NIH study

Sister Study, 2022

Increased uterine cancer risk

2.5×

Free, Confidential Case Evaluation

Tell us what happened. We’ll tell you whether you have a case.

No fee unless we recover for you. All consultations are confidential and protected by attorney–client privilege.